Pfizer is boosting its presence in China by partnering with local drug companies and increasing its Asian sales force, a company official said. Jean-Michel Halfon, Pfizer's head of emerging markets, said China and other emerging markets have "very good profitability," even though the company cannot charge as much for drugs there.

Full Story:

Related Summaries